Gen1e
2 known investors
GEn1E is a biotech company developing next-generation substrate-specific p38α kinase inhibitors to treat rare and inflammatory diseases. It uses a curated database linking genes, pathways, proteins, diseases, and compounds along with machine learning models spanning drug discovery through clinical trials to accelerate its drug development.